Evidence map›Paper›PMID 35625914›Full record

ArticleBiomedicines2022

A Very Rare Variant in

Ana-Bárbara García-García, Sergio Martínez-Hervás, Santiago Vernia, Carmen Ivorra, Inés Pulido, Juan-Carlos Martín-Escudero, Marta Casado, Julián Carretero, José T Real, Felipe Javier Chaves

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Ana-Bárbara García-GarcíaCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain.ORCID 0000-0002-2162-6606
Sergio Martínez-HervásCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain.ORCID 0000-0002-6775-2034
Santiago VerniaBiomedical Institute of Valencia (IBV-CSIC), 46010 Valencia, Spain.
Carmen IvorraGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Inés PulidoUniversity of Illinois Hospital & Health Sciences System Cancer Center, University of Illinois Chicago, Chicago, IL 60612, USA.ORCID 0000-0002-1637-6702
Juan-Carlos Martín-EscuderoInternal Medicine Service, Rio Hortega Hospital, 47012 Valladolid, Spain.
Marta CasadoBiomedical Institute of Valencia (IBV-CSIC), 46010 Valencia, Spain.ORCID 0000-0001-6457-4650
Julián CarreteroDepartment of Physiology, University of Valencia, 46010 Valencia, Spain.
José T RealCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain.
Felipe Javier ChavesCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029 Madrid, Spain.ORCID 0000-0001-8009-3689
Universitat de València · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESHospital Universitario Río Hortega · ESINCLIVA Health Research Institute · ESInstituto de Biomedicina de Valencia · ES

Funding

Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas AsociadasFondo Investigaciones Sanitarias. Instituto de Salud Carlos III PI17/0497Fondo Investigaciones Sanitarias. Instituto de Salud Carlos III PI21/00506Generalitat Valenciana AP11-091Medical Research Council MC_UP_1102/18
6 · The paper itself

Abstract

Patients with high cholesterol and glucose levels are at high risk for cardiovascular disease. The Sterol Regulatory Element Binding Protein (SREBP) system regulates genes involved in lipid, cholesterol and glucose pathways. Autosomal Dominant Hypercholesterolemias (ADHs) are a group of diseases with increased cholesterol levels. They affect 1 out of every 500 individuals. About 20-30% of patients do not present any mutation in the known genes (

Indexed as

diabetesgenetic diseasehyperglycemiahyperlipidemiamutationSREBP system

Identifiers

PMID35625914
PMCPMC9138625
OpenAlexW4280576634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.